Clinical trial Recruiting at 1 site Interventional Ages 40 to 60

Rhythmic Initiation vs Isometric Training for Arm Recovery After Stroke

Official title: Comparative Effects of Rhythmic Initiation and Isometric Resistance Training on Upper Limb Motor Function, Strength, and Coordination in Subacute Stroke Patients

Run by University of Faisalabad · NCT07598435 · Data updated 2026-11-12

This trial tests whether Rhythmic Initiation or Isometric Resistance Training helps improve upper-limb function in people who recently had a first stroke.

Quick facts

Study typeInterventional
Ages40 Years to 60 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Faisalabad
Academic / other
Locations1 site (Faisalābad, Punjab Province)
StatusRecruiting
StartedJanuary 19, 2026
Main results expectedMay 19, 2026
Study endsJune 24, 2026
Registry record updatedJune 3, 2026
Trial IDNCT07598435 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–60 with a first-time subacute unilateral upper-limb stroke (1–6 months) and sufficient ability to participate in physical therapy.

Probably not a fit

Patients with severe spasticity (Modified Ashworth >3), recurrent or bilateral stroke, or significant shoulder conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this single-blind, parallel-arm study, adults aged 40–60 with a new subacute stroke and unilateral arm weakness are randomized to receive either Rhythmic Initiation (a PNF-based, progressive movement therapy) or Isometric Resistance Training for 30 minutes per session, five days a week for four weeks. Participants are recruited from the University of Faisalabad in Pakistan and allocated 1:1 to the two therapies; outcome assessors are blinded to treatment. The trial focuses on restoring motor control and strength in the affected upper limb using structured, therapist-guided exercises. Eligible individuals must have subacute stroke (1–6 months post-onset), no severe spasticity or contraindicating conditions, and be able to participate in therapy. The primary aim is to compare the two approaches for improving upper-limb motor function in this population.

Why it matters

Potential benefit: If successful, the study could identify a more effective therapy for improving arm strength and control after subacute stroke.

How similar studies have gone: Prior rehabilitation approaches using PNF or isometric training have shown potential benefits, but direct comparison in this specific subacute window is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinically diagnosed subacute stroke (1 to 6 months post-onset)
* Unilateral upper limb involvement
* Age 40 to 60 years
* Both genders
* Medically stable and able to participate in physical therapy
* Able to provide informed consent

Exclusion Criteria:

* Severe spasticity (Modified Ashworth Scale score \>3)
* Recurrent or bilateral stroke
* Shoulder subluxation
* Shoulder or upper limb pain limiting active movement
* Cognitive or perceptual deficits impairing ability to follow instructions
* Other neurological disorder affecting upper limb (e.g., Parkinson's disease, multiple sclerosis)
* Orthopedic condition affecting upper limb function

Where it's running

  • The University of Faisalabad
    Faisalābad, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.